Clever Culture Systems Limited
CC5
Rangering i aksjer
#27449
Based in Adelaide, Australia, Clever Culture Systems Limited, established in... Based in Adelaide, Australia, Clever Culture Systems Limited, established in 2004, focuses on the innovation, development, and market launch of advanced technological solutions for the medical industry. The company operates internationally, serving markets in Australia, the United States, Sweden, the United Kingdom, China, the Netherlands, and Germany. Its core offering is the Automated Plate Assessment System (APAS), which efficiently images, analyzes, and interprets microbiology culture plates, primarily assisting microbiology laboratories and the pharmaceutical manufacturing sector. The company's portfolio also includes Digital Microbiology and specialized APAS modules—artificial intelligence algorithms designed to enable digital reading of culture plates when integrated with the APAS Independence system. Additionally, Clever Culture Systems is advancing its APAS intelligent imaging technology for diverse applications, including urine screening, infection control testing, and assessing antimicrobial susceptibility. Formerly known as LBT Innovations Limited, the company adopted its current name in November 2024.
Aksjekurs
$0.0141057
Sist synkronisert: 2026-10-20
Markedsverdi
$30.78M
Endring (1 dag)
0.00%
Endring (1 år)
32.83%
Land
AU
Handel Clever Culture Systems Limited (CC5)
Kategori
Healthcare
Inntekter for Clever Culture Systems Limited (CC5)
Inntekter i Jun 2024 TTM: $838.62K
Ifølge de nyeste økonomiske rapportene til Clever Culture Systems Limited er selskapets nåværende inntekter (TTM) $838.62K. I 2023 hadde selskapet inntekter på $1.42M en nedgang sammenlignet med inntektene i 2022, som var $1.47M. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Clever Culture Systems Limited fra 2007 til 2026
Inntekter ved slutten av hvert år
| År | Inntekter | Endre |
|---|---|---|
| 2026 (TTM) | $838.62K | 0.00% |
| 2024 | $838.62K | -40.96% |
| 2023 | $1.42M | -3.22% |
| 2022 | $1.47M | 74.31% |
| 2021 | $842.03K | 5.02% |
| 2020 | $801.78K | 281.82% |
| 2019 | $209.99K | -70.19% |
| 2018 | $704.34K | 177.17% |
| 2017 | $254.12K | -95.58% |
| 2016 | $5.76M | 215.82% |
| 2015 | $1.82M | -51.59% |
| 2014 | $3.76M | -5.06% |
| 2013 | $3.97M | 360.75% |
| 2012 | $860.56K | 60.52% |
| 2011 | $536.12K | -83.24% |
| 2010 | $3.20M | 98.41% |
| 2009 | $1.61M | -10.05% |
| 2008 | $1.79M | -37.82% |
| 2007 | $2.88M | 0.00% |
Inntekter for lignende selskaper eller konkurrenter
| Selskap | Inntekter | Forskjell i inntekter | Land |
|---|---|---|---|
| $46.34B | 5,525,135.84% |
US
|
|
| $25.11B | 2,993,729.77% |
US
|
|
| $2.71B | 322,699.53% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 878,958.15% |
US
|
